Posted on October 12th, 2015 by msequeira
|WHAT:||The Turquoise Trail Harley Owners’ Group plans to end its “Pink Your Ride — Motorcyclists Increasing Awareness (MIA)” ride at the University of New Mexico Comprehensive Cancer Center.|
|WHY:||Two sisters who belong to a HOG Chapter in Pennsylvania started the ride in 2012 to honor a third sister, nicknamed Mia, who lost her battle with breast cancer. This year, their ride will include more than 100 motorcycles. They invited other HOG chapters around the country to join the ride by riding on the same day.
The Turquoise Trail Chapter chose to join the Pennsylvania chapter ride because of the widespread impact breast cancer has in New Mexico and in the United States. They hope to encourage others to join the ride here in the state and elsewhere in the country.
The Turquoise Trail motorcyclists will ride from Thunderbird Harley Davidson to the UNM Comprehensive Cancer Center.
|WHERE:||The ride will leave from Thunderbird Harley Davidson, 5000 Alameda Blvd, NE, Albuquerque, and end at the UNM Cancer Center, 1201 Camino de Salud, Albuquerque.|
|WHEN:||Saturday, October 17, 2015.
Riders will arrive at UNM Cancer Center at approximately 1:00 p.m.
|INTERVIEWS:||Monika Barela, email@example.com, 505-259-4356|
|CONTACT:||Dorothy Hornbeck, JKPR, 505-340-5929, firstname.lastname@example.org
Michele Sequeira, UNM Cancer Center, 505-925-0486, email@example.com
The University of New Mexico Comprehensive Cancer Center is the Official Cancer Center of New Mexico and the only National Cancer Institute-designated Cancer Center in a 400-mile radius. One of the premier cancer centers nationwide, the UNM CCC has 128 board-certified oncology physicians, forming New Mexico’s largest cancer care team. It treats about 60 percent of adults and virtually all the children in New Mexico diagnosed with cancer — more than 10,000 people— from every county in the state in more than 135,000 clinic visits each year. Through its partnership with the New Mexico Cancer Care Alliance, an “exemplary national model for cancer health care delivery,” the UNM CCC offers access to more than 160 clinical trials to New Mexicans in every part of the state. Annual research funding of more than $72 million supports the UNM CCC’s 132 cancer scientists. Working with partners at Los Alamos and Sandia National Laboratories, Lovelace Respiratory Research Institute, and New Mexico State University, they have developed new diagnostics and drugs for leukemia, breast cancer, ovarian cancer, prostate cancer, liver and pancreatic cancer, brain cancer, and melanoma; garnered 33 new patents and 117 patents pending; and launched 13 new biotechnology companies since 2010. Learn more at http://www.cancer.unm.edu.
You must be logged-in to the site to post a comment.